PET-positive | |||||||
Author | Year | PET/CT probe | Median PSA level (ng/mL) | Patients (n) | n | % | Change in radiotherapy plan (%) |
Würschmidt | 2011 | 18F-choline | 10.4 (range, 2.5–731) | 7 | 7 | 100 | 28.50 |
Vees | 2012 | 18F-choline | 30.5 (range, 6.4–66.5) | 19 | NA | NA | 22 |
Jereczek-Fossa | 2014 | 11C-choline | NA | 16 | NA | NA | 12.50 |
Garcia | 2015 | 11C-choline | NA (range, 6.3–30.4) | 61 | 61 | 100 | 24.50 |
López | 2014 | 11C-choline | 18.18 (range, 4.90–55.40) | 9 | NA | NA | 44 |
Alongi | 2015 | 18F-choline | 6.5 (range, 4.1–143) | 60 | 57 | 95 | 21.60 |
Sterzing | 2016 | 68Ga-PSMA | 7.04 (range, 0.28–45) | 15 | 9 | 60 | 26.50 |
Dewes | 2016 | 68Ga-PSMA | 13.5 (range, 8.2–63.9) | 15 | 15 | 100 | 33.30 |
NA = not applicable.